Orexigen Therapeutics, Inc. Sets IPO at 6 Million Shares, $11-$13 Each

April 10, 2007 |

1 min read

WASHINGTON, April 9 (Reuters) - Biopharmaceutical company Orexigen Therapeutics on Monday said it is planning an initial public offering of 6 million shares for between $11 and $13 per share.

>>> Discuss This Story

IPO

MORE ON THIS TOPIC

A train with blue background, 3d rendering. Computer digital drawing.

Mergers & acquisitions

Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos

March 24, 2026

·

3 min read

·

Tristan Manalac

Illustration showing a handshake, signaling cooperation, goodwill

Immunology and inflammation

Sanofi Keeps Immuno Deals Coming With Kali Bet Worth Potential $1B+

March 23, 2026

·

2 min read

·

Tristan Manalac

Hand collage holding dollar paper money isolated on yellow background. Using cash to buy concept. Halftone effect in pop art style illustration.

Breast cancer

Novartis Buys Breast Cancer Drug for $2B to Keep Up With Myriad Rivals

March 20, 2026

·

2 min read

·

Tristan Manalac

The person launches paper airplane. Art collage.

Approvals

Protagonist’s First Approval Spells Trouble for Pharma’s Immunology Heavyweights

March 18, 2026

·

3 min read

·

Annalee Armstrong